| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
|
|
|
|
|||||||||||||
|
|
|||||||||||||||
LUNG CANCER |
1 Eindhoven Cancer Registry, Comprehensive Cancer Center South (IKZ), Eindhoven, The Netherlands
2 Catharina Hospital, Department of Pulmonary Diseases, Eindhoven, The Netherlands
3 Jeroen Bosch Hospital, Department of Surgery, Den Bosch, The Netherlands
4 Erasmus University Medical Centre, Department of Public Health, Rotterdam, The Netherlands
Correspondence to:
Correspondence to:
Dr M L G Janssen-Heijnen
Eindhoven Cancer Registry, Comprehensive Cancer Center South (IKZ), P O Box 231, 5600 AE Eindhoven, The Netherlands; research{at}ikz.nl
Background: With the rising mean age, more patients will be diagnosed with one or more other serious diseases at the time of lung cancer diagnosis. Little is known about the best way to treat elderly patients with comorbidity or the outcome of treatment. This study was undertaken to evaluate the independent effects of age and comorbidity on treatment and prognosis in patients with non-small cell lung cancer (NSCLC).
Methods: All patients with NSCLC diagnosed between 1995 and 1999 in the southern part of the Netherlands (n = 4072) were included.
Results: The proportion of patients with localised NSCLC who underwent surgery was 92% in patients younger than 60 years and 9% in those aged 80 years or older. In patients aged 60–79 years this proportion also decreased with comorbidity. In patients with non-localised NSCLC the proportion receiving chemotherapy was considerably higher for those aged less than 60 years (24%) than in those aged 80 or older (2%). The number of comorbid conditions had no significant influence on the treatment chosen for patients with non-localised disease. Multivariable survival analyses showed that age, tumour size, and treatment were independent prognostic factors for patients with localised disease, and stage of disease and treatment for those with non-localised disease. Comorbidity had no independent prognostic effect.
Conclusions: It is questionable whether the less aggressive treatment of elderly patients with NSCLC is justified.
Keywords: comorbidity; lung cancer; treatment; prognosis; elderly
This article has been cited by other articles:
|
|
 |
|
  A. Bezjak, C. W. Lee, K. Ding, M. Brundage, T. Winton, B. Graham, M. Whitehead, D. H. Johnson, R. B. Livingston, L. Seymour, et al. Quality-of-Life Outcomes for Adjuvant Chemotherapy in Early-Stage Non-Small-Cell Lung Cancer: Results From a Randomized Trial, JBR.10 J. Clin. Oncol., November 1, 2008; 26(31): 5052 - 5059. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. G. Blanco, I. S. Toste, R. F. Alvarez, G. R. Cuadrado, A. M. Gonzalvez, and I. J. G. Martin Age, comorbidity, treatment decision and prognosis in lung cancer Age Ageing, November 1, 2008; 37(6): 715 - 718. [Full Text] [PDF]
|
|
|
|
 |
|
 D. De Ruysscher, A. Botterweck, M. Dirx, M. Pijls-Johannesma, R. Wanders, M. Hochstenbag, A. -M. C. Dingemans, G. Bootsma, W. Geraedts, J. Simons, et al. Eligibility for concurrent chemotherapy and radiotherapy of locally advanced lung cancer patients: a prospective, population-based study Ann. Onc., August 20, 2008; (2008) mdn559v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. K. Bernstein and S. Deshpande Preoperative Evaluation for Thoracic Surgery Seminars in Cardiothoracic and Vascular Anesthesia, June 1, 2008; 12(2): 109 - 121. [Abstract] [PDF]
|
|
|
|
 |
|
 S. Taneja, S. Mandayam, Z. Z. Kayani, Y.-F. Kuo, and V. B. Shahinian Comparison of Stage at Diagnosis of Cancer in Patients Who Are on Dialysis versus the General Population Clin. J. Am. Soc. Nephrol., September 1, 2007; 2(5): 1008 - 1013. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Lopez-Encuentra, A. Gomez de la Camara, R. Rami-Porta, J. L. Duque-Medina, J. L. M. de Nicolas, J. Sayas, and the Bronchogenic Carcinoma Cooperative Group of th Previous tumour as a prognostic factor in stage I non-small cell lung cancer Thorax, May 1, 2007; 62(5): 386 - 390. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Sugimura and P. Yang Long-term Survivorship in Lung Cancer: A Review. Chest, April 1, 2006; 129(4): 1088 - 1097. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Birim, A. P. Kappetein, and A. J.J.C. Bogers Charlson comorbidity index as a predictor of long-term outcome after surgery for nonsmall cell lung cancer Eur. J. Cardiothorac. Surg., November 1, 2005; 28(5): 759 - 762. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Maione, F. Perrone, C. Gallo, L. Manzione, F. Piantedosi, S. Barbera, S. Cigolari, F. Rosetti, E. Piazza, S. F. Robbiati, et al. Pretreatment Quality of Life and Functional Status Assessment Significantly Predict Survival of Elderly Patients With Advanced Non--Small-Cell Lung Cancer Receiving Chemotherapy: A Prognostic Analysis of the Multicenter Italian Lung Cancer in the Elderly Study J. Clin. Oncol., October 1, 2005; 23(28): 6865 - 6872. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K Miyazaki, N Kikuchi, H Satoh, K Sekizawa, M L G Janssen-Heijnen, and J W W Coebergh Comorbidity in elderly NSCLC patients Thorax, August 1, 2005; 60(8): 704 - 704. [Full Text] [PDF]
|
|
|
|
|
|
L Dertsiz, G Ozbilim, Y Kayisli, G A Gokhan, A Demircan, and U A Kayisli Differential expression of VASP in normal lung tissue and lung adenocarcinomas Thorax, July 1, 2005; 60(7): 576 - 581. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. C. Detterbeck Life in the Real World Chest, March 1, 2005; 127(3): 699 - 701. [Full Text] [PDF]
|
|
|
|
|
|
D Sortini, E Pozza, K Maravegias, A Liboni, A Sortini, M L G Janssen-Heijnen, H J A A van Geffen, V E P P Lemmens, F W J M Smeenk, S A Smulders, et al. Surgery in early NSCLC and co-morbidity * Authors' reply Thorax, March 1, 2005; 60(3): 256 - 257. [Full Text] [PDF]
|
|
Read all eLetters
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
